Using AI to detect heart rhythm disorders from ECGs
Official title: Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias
Run by Assistance Publique - Hôpitaux de Paris · NCT05829993 · Data updated 2026-11-12
This study is testing a new AI tool that looks at ECGs to see if it can better identify types of Long QT syndrome and the risk of dangerous heart rhythms for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | November 28, 2023 |
| Main results expected | May 28, 2027 |
| Study ends | June 28, 2027 |
| Registry record updated | July 31, 2025 |
| Trial ID | NCT05829993 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who require an ECG for clinical evaluation.
✕Probably not a fit
Patients with medical contraindications for ECG or those with pacemaker-driven QRS may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to validate an artificial intelligence model that analyzes ECGs to automatically measure various features and identify types of Long QT syndrome (LQT) and the associated risk of Torsade-de-Pointes (TdP). It focuses on the relationship between ventricular repolarization abnormalities and the risk of potentially fatal ventricular arrhythmias. By leveraging deep learning techniques, the study seeks to enhance the predictive capabilities of ECG analysis beyond traditional measurements. The research will be conducted in real-life cohorts across multiple departments of the Assistance Publique - Hôpitaux de Paris.
Why it matters
Potential benefit: If successful, this study could lead to improved detection and risk assessment of life-threatening heart rhythm disorders, potentially saving lives.
How similar studies have gone: Other studies utilizing AI for ECG analysis have shown promising results, indicating that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 * Patients or subjects taken care in recruiting centres for which an ECG is indicated * No opposition to participation in the study Exclusion Criteria: * Medical contraindication for ECG * Subjects with pacemaker-driven QRS
Where it's running
-
Centre d'Investigation Clinique Paris-Est/Hôpital Pitié-Salpêtrière
Paris, France Recruiting
Study contacts
- Principal investigator: Joe-Elie SALEM, PU-PH — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Joe-Elie SALEM, PU-PH
- Email: joe-elie.salem@aphp.fr
- Phone: 0033 1 42 17 85 35
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Balance in Everyday Life for young MI patients with distress
This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.
-
Well-being program for caregivers of patients with advanced heart or lung disease
This study tests an 8-week, home-based wellness program delivered virtually to caregivers of people with advanced cardiac or pulmonary disease to see if it’s feasible and acceptable.
-
Digital diagnosis of newborn heart sounds
This project will test a digital, machine-learning tool that listens to newborn heart sounds to try to detect serious congenital heart problems in the first month of life.
-
Comparing the Optrell mapping catheter for papillary muscle ventricular arrhythmias
This test sees if the Optrell mapping catheter helps doctors map and treat papillary muscle ventricular arrhythmias faster and more accurately in adults having ablation.
-
Efferon LPS hemoadsorption during and after heart surgery
This trial tests whether using the Efferon® LPS filter during cardiopulmonary bypass and again within 24 hours afterward can lower the chance and severity of multiple organ dysfunction in adults having cardiac surgery who are at higher surgical risk.
-
RHYthm and Myocardial Function Relationship in Heart Disease
This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.